全文获取类型
收费全文 | 21568篇 |
免费 | 2978篇 |
国内免费 | 472篇 |
专业分类
耳鼻咽喉 | 107篇 |
儿科学 | 365篇 |
妇产科学 | 292篇 |
基础医学 | 882篇 |
口腔科学 | 268篇 |
临床医学 | 4457篇 |
内科学 | 2399篇 |
皮肤病学 | 304篇 |
神经病学 | 858篇 |
特种医学 | 502篇 |
外国民族医学 | 1篇 |
外科学 | 1492篇 |
综合类 | 1955篇 |
一般理论 | 4篇 |
预防医学 | 3672篇 |
眼科学 | 245篇 |
药学 | 5325篇 |
50篇 | |
中国医学 | 1327篇 |
肿瘤学 | 513篇 |
出版年
2024年 | 79篇 |
2023年 | 728篇 |
2022年 | 800篇 |
2021年 | 1481篇 |
2020年 | 1534篇 |
2019年 | 1390篇 |
2018年 | 1320篇 |
2017年 | 1297篇 |
2016年 | 1225篇 |
2015年 | 1160篇 |
2014年 | 1831篇 |
2013年 | 2359篇 |
2012年 | 1510篇 |
2011年 | 1332篇 |
2010年 | 1075篇 |
2009年 | 958篇 |
2008年 | 842篇 |
2007年 | 766篇 |
2006年 | 694篇 |
2005年 | 553篇 |
2004年 | 376篇 |
2003年 | 294篇 |
2002年 | 281篇 |
2001年 | 228篇 |
2000年 | 153篇 |
1999年 | 100篇 |
1998年 | 108篇 |
1997年 | 66篇 |
1996年 | 85篇 |
1995年 | 63篇 |
1994年 | 44篇 |
1993年 | 30篇 |
1992年 | 49篇 |
1991年 | 31篇 |
1990年 | 23篇 |
1989年 | 19篇 |
1988年 | 17篇 |
1987年 | 19篇 |
1986年 | 18篇 |
1985年 | 17篇 |
1984年 | 16篇 |
1983年 | 12篇 |
1982年 | 5篇 |
1981年 | 6篇 |
1980年 | 8篇 |
1979年 | 3篇 |
1978年 | 3篇 |
1977年 | 3篇 |
1976年 | 2篇 |
1972年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
61.
62.
Thomas R. Russell 《American journal of surgery》2009,197(6):826-827
In recent years, the surgical profession has attempted to incorporate into clinical practice certain techniques that the airline industry has used to improve safety. These mechanisms have proven to be valuable components of our efforts to ensure that surgical patients receive safe, high-quality care. However, as the authors of “Cost and workforce implications of subjecting all physicians to aviation industry work hour restrictions” note, it would be a mistake to extend aviation's work-hour restrictions to medicine, particularly to resident training programs. 相似文献
63.
64.
J A Thomson 《Injury prevention》2006,12(3):138-139
65.
66.
目的观察针刺推拿中药综合治疗颈性眩晕的疗效。方法设综合组80例、电针组42例、推拿组68例和中药组36例,进行疗效比较分析。结果综合组有效率为93.8%,电针组有效率为73.8%,推拿组有效率为86.8%,中药组有效率为69.4%,综合组有效率与其他几组比较差异均有统计学意义(P〈0.05)。结论采用电针、推拿、中药相结合的综合疗法治疗颈性眩晕集诸单一疗法之精华,避免单一疗法的局限性,可提高有效率。 相似文献
67.
Internal auditing is a key mechanism in enhancing organizational reliability. However, research on the ways quality internal auditing is enabled through learning, deterrence, motivation and process improvement is scant. In particular, the relational underpinnings of internal auditing have been understudied. This study attempts to address this need by examining how organizational trust, perceived organizational support and psychological safety enable internal auditing. Data collected from employees in medical clinics of one of the largest healthcare organizations in Israel at two points in time six months apart. Our results show that organizational trust and perceived organizational support are positively related to psychological safety (measured at time 1), which, in turn, is associated with internal auditing (measured at time 2). 相似文献
68.
云克治疗类风湿关节炎临床疗效观察 总被引:1,自引:0,他引:1
目的:观察云克 (99Tc- MDP)治疗类风湿关节炎 (RA)的疗效。 方法:对 80例类风湿关节炎 (RA)患者应用云克进行静脉治疗 2 1d,并对治疗前后的相关指标进行对照分析。结果 :治疗前与治疗后相比 ,患者晨僵持续时间、握力、ESR、CRP、RF有统计学意义 (P <0 .0 5 ) ,患者关节压痛数及关节肿胀数差异无统计学意义 (P >0 .0 5 )。 结论:云克治疗类风湿关节炎能改善临床症状及实验室指标 ,远期疗效好 ,而且毒副作用小。 相似文献
69.
LI Wei-yong LI Qian QIAO Jian DENG Jun-gang ZHANG Ying 《中国临床药理学与治疗学》2007,12(10):1182-1183
AIM: To determine the safety, tolerability and pharmacokinetic parameters of a new drug recombinant human parathyroid hormone [ rhPTH (1-84)] in healthy male Chinese subjects. METHODS: domly divided Thirty-six healthy male volunteers were rangroups received into 3 groups. The volunteers in these single subcutaneous injection of rhPTH ( 1-84) in a dosage of 1, 2 and 4 μg/kg respectively. Blood samples were obtained before and after administration within 24 hours. The rhPTH concentrations in sennn were determined by enzyme linked immunosorbent assay (ELISA). The pharmacokinetic parameters determined with use of standard noncompartmental analysis were the maximum serum concentration ( Cmax ), the time to attain that concentration ( tmax ), and the area under the serum concentration-time curve up to 24 hours( AUC0-24 ) and up to infinity (AUC0-∞). Dose proportionality of pharmacokinetic parameters (AUC, Cmax of every volunteer of each dosage and A UC was computed from log transformed data) and was examined by mean of analysis of variance (ANOVA) using SPSS software package. In the study, subjects' symptoms, objective signs, and vital signs, including blood pressure, heart rate, respiratory rate and body temperature, were checked and 12-lead electrocardiography was recorded before and after drug administration within 24 hours. Routine laboratory tests, including hematology, blood biochemistry, serum electrolyte, and urinalysis, were performed before and after drug administration within at 24 hours.[第一段] 相似文献
70.
AIMS: To compare long-term (1 year) efficacy and safety of pioglitazone and gliclazide in patients with Type 2 diabetes. METHODS: This was a double-blind, multicentre, comparative, parallel group trial in 283 patients with Type 2 diabetes, who were randomized to receive 1-year treatment with pioglitazone 30-45 mg/day or gliclazide 80-320 mg/day. Drug dose was titrated on the basis of self-monitored blood glucose (SMBG) measurements and HbA1c values. The 1-year changes in HbA1c, fasting blood glucose (FBG), insulin, HOMA-S (HOmeostatic Model Assessment) and SMBG were compared. In a subgroup of patients (n = 10), systemic glucose production and utilization were determined by a combination of isotopic (deuterated glucose) and clamp techniques. RESULTS: In both groups, there were similar decreases in HbA1c (pioglitazone: -0.79%; gliclazide: -0.79%) and FBG (pioglitazone: -1.0 mmol/l; gliclazide: -0.7 mmol/l), whereas the slope of the reduction of fasting blood glucose was different between groups (P = 0.004). Insulin levels as well as insulin resistance assessed using HOMA-S decreased significantly only after pioglitazone treatment (-11.94 pmol/l and -1.03, respectively, both P = 0.002 vs. baseline). A significantly greater reduction in systemic glucose production was observed in the pioglitazone group (-2.48 micromol/kg/min, P = 0.042) than in the gliclazide group (-1.02 micromol/kg/min). A few, mild adverse events occurred in both groups. CONCLUSIONS: A comparable decrease in HbA1c and FBG was observed with pioglitazone and gliclazide. However, with pioglitazone there was a continuous decrease in FBG over 1 year, whereas gliclazide failed to maintain a similar trend. This favourable effect of pioglitazone was due to its insulin-sensitizing effect and ability to decrease systemic glucose production. 相似文献